» Authors » Swagata Goswami

Swagata Goswami

Explore the profile of Swagata Goswami including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 110
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Goswami S, Dutta D, Pandey S, Chattopadhyay P, Lalhmunsiama , Dubey R, et al.
J Environ Manage . 2024 May; 359:121063. PMID: 38704955
Due to the potential harm caused by emerging micro-pollutants to living organisms, contaminating water supplies by micro-pollutants like EDCs, pharmaceuticals, and microorganisms has become a concern in many countries. Considering...
2.
Goswami S, Dutta D, Lalhmunsiama , Dubey R, Tiwari D, Jung J
Sci Total Environ . 2024 Apr; 929:172546. PMID: 38636858
Micro-pollutants (specifically antibiotics and personal care products) and potential bacterial contamination pose a severe threat to human health and marine life. The study derives indigenous novel fibrous hydrophobic nanocomposite, efficient...
3.
Zhang Q, Goswami S, Yilmaz O
Nat Cell Biol . 2024 Jan; 26(1):41-42. PMID: 38168771
No abstract available.
4.
Goswami S, Zhang Q, Celik C, Reich E, Yilmaz O
Biochim Biophys Acta Rev Cancer . 2023 Sep; 1878(6):188984. PMID: 37722512
Metabolic reprogramming has been considered a core hallmark of cancer, in which excessive accumulation of lipids promote cancer initiation, progression and metastasis. Lipid metabolism often includes the digestion and absorption...
5.
Das P, Devi N, Gaur N, Goswami S, Dutta D, Dubey R, et al.
Sci Rep . 2023 Apr; 13(1):6209. PMID: 37069316
In this work, five acrylonitrile adducts were screened for antibacterial activity against Gram-positive Bacillus subtilis, Microbial Type Culture Collection and Gene Bank (MTCC 1305) and Gram-negative Escherichia coli (MTCC 443)....
6.
Goswami S, Chiang C, Zapolnik K, Nunes J, Ventura A, Mo X, et al.
Leuk Res . 2022 May; 118:106872. PMID: 35640397
No abstract available.
7.
Goswami S, Mani R, Nunes J, Chiang C, Zapolnik K, Hu E, et al.
Blood . 2021 Nov; 139(9):1340-1358. PMID: 34788382
Dysregulated cellular differentiation is a hallmark of acute leukemogenesis. Phosphatases are widely suppressed in cancers but have not been traditionally associated with differentiation. In this study, we found that the...
8.
Hu E, Do P, Goswami S, Nunes J, Chiang C, Elgamal S, et al.
Blood Adv . 2021 Aug; 5(16):3152-3162. PMID: 34424320
Antibody-drug conjugates directed against tumor-specific targets have allowed targeted delivery of highly potent chemotherapy to malignant cells while sparing normal cells. Receptor tyrosine kinase-like orphan receptor 1 (ROR1) is an...
9.
Xie Z, Chen M, Goswami S, Mani R, Wang D, Kulp S, et al.
AAPS J . 2020 Jul; 22(4):92. PMID: 32676788
In this study, we characterized the pharmacokinetics of OSU-2S, a fingolimod-derived, non-immunosuppressive phosphatase activator, in mice, rats, and dogs, as well as tolerability and food effects in dogs. Across all...
10.
Hofmann M, Mani R, Engelhardt H, Impagnatiello M, Carotta S, Kerenyi M, et al.
Mol Cancer Ther . 2020 Feb; 19(4):1018-1030. PMID: 32024684
Natural killer (NK) cells play a pivotal role in controlling cancer. Multiple extracellular receptors and internal signaling nodes tightly regulate NK activation. Cyclin-dependent kinases of the mediator complex (CDK8 and...